Ecological footprint of the pharmaceutical industry in Germany
Association of Research-based Pharmaceutical Companies (VFA)
ongoing
The transition of the economy and society as a whole to a climate-neutral economy and way of living remains one of the key challenges facing us today. A fundamental component for the achievement of climate neutrality is the reduction of greenhouse gas emissions produced by industry but also making industrial processes more sustainable.
On behalf of the Association of Research-based Pharmaceutical Companies (vfa), Prognos examined the global ecological footprint of the pharmaceutical industry in Germany. For this purpose, Prognos determined the global climate-damaging emissions, water consumption and energy use generated by the pharmaceutical industry and then compared this data with other sectors in Germany as well as relevant pharmaceutical locations abroad.
It is important to highlight the global nature of the study as previous investigations have limited their consideration to emission load and use of resources at regional level. Emissions or resource intensive processes that are shifted abroad are not usually assigned to inland industry. This means that an industrial sector can be responsible for significant amounts of climate-damaging emissions globally, but still appear sustainable from a national perspective and even fulfil national industry targets. For the first time, the global view used in the current study applies a more transparent approach to the sector.
Overall, the pharmaceutical industry in German takes a leading role on the path to ecological sustainability.
The ecological footprint of the German pharmaceutical industry was established for three categories: greenhouse gas emissions, water consumption, energy use. We used a method established in the scientific literature to determine emissions and consumption along the entire value chain of the German pharmaceutical industry, both nationally and internationally. In essence, data on global value chains from the OECD database TIVA (Trade in Value Added) is linked to information on industry-specific emissions and consumption intensities.
The study (vfa website in German)
Project team: Jakob Ambros, Leilah Dismond, Dr Andreas Sachs
Last update: 15.01.2024
Project Manager
Foreign trade, employment, investment and raw materials: ahead of the new US administration taking office, we analysed for the Süddeutsche Zeitung how dependent our economy is on the US and China.
German industry can increase the resilience of its supply chains by sourcing its intermediate products from different countries. We have analyzed these new procurement markets.
Even if the global trade in goods is no longer growing, there are still promising markets for German business. We present 13 potential markets in Asia and Latin America.
German industry is dependent on raw materials and preliminary products from abroad. On behalf of the Netzwerk Zukunft der Industrie e. V., Prognos analyses the supply chains and provides recommendations for action.
A race to catch up - this is what Europe needs if it is not to be left behind by the USA and China. In the SPIEGEL guest article, Christian Böllhoff calls for a new match plan with clear priorities for the new EU legislative period.
Growth in the German economy benefits the whole of Europe. Our study for the vbw shows that this is due to the size of the economy and its strong foreign trade networks.
Prognos develops a tool for an industry association that enables member companies to carry out risk analyses to identify sustainability risks in countries and sectors.
In his guest article "Move Europe - it's urgent!" in WirtschaftsWoche, Christian Böllhoff calls for Europe to reposition itself geo-economically in order to strengthen its position between the economic giants USA and China.
Germany and Europe are trying to find their place in the New World Order. Prognos examined four foreign trade strategies for the vbw.
An industry association commissioned us to create a guide to successfully implement the materiality analysis for its member companies in accordance with the new European CSRD directive.
Prognos is one of the oldest economic research centres in Europe. Founded at the University of Basel, Prognos experts have been conducting research for a wide range of clients from the public and private sectors since 1959 – politically independent, scientifically sound.